Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...

It also aligns with a strategy that 23andMe had been pursuing for years. The Regeneron Biotechnology company logo is seen displayed on a smartphone. (Igor Golovniov/SOPA Images/LightRocket via ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced a license and collaboration agreement with Ultragenyx Pharmaceutical Inc. to develop, commercialize and distribute Evkeeza outside of ...